MedTrace Logo

CORE Study COVID-19

NCT04531202 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-08-28

No results posted yet for this study

Summary

This is a Brazilian version of the Clinical Characterization Protocol for Serious Emerging Infections (ISARIC/WHO ). This is a standardized protocol for the rapid, coordinated clinical investigation of Coronavirus disease (COVID-19). Patients with acute illness suspected to be caused by emerging will be enrolled. This protocol has been designed to enable data to be prospectively collected.

Conditions

  • Coronavirus Infection (COVID-19)

Sponsors & Collaborators

  • D'Or Institute for Research and Education

    lead OTHER

Principal Investigators

  • Fernando Bozza, phD · D'Or Institute for Research and Education (IDOR)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-02
Primary Completion
2020-09-30
Completion
2021-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04531202 on ClinicalTrials.gov